| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a73cee5001ad08339ae751c10d9abf71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be2ec1bfde15bb7491c24027e8d66001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b47be825e111c71394a2c620b4dbffe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eeac314a9eaf53b8fd88b99b697a25a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecbe9664a4ed9d8adabf23b5fa03fc61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1891e0bd6a763df157313299f489621f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5aa9adb79b91cc60a0082ed1f17b426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84370630edcfd9ecf967d1a9cef4be0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cbb9a1bce8fef802d6b3dbbd1de64f3 |
| publicationDate |
2022-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3510032-B1 |
| titleOfInvention |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer |
| priorityDate |
2016-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |